Emerald Mutual Fund Advisers Trust bought a new position in shares of Zevia PBC (NYSE:ZVIA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 297,229 shares of the company's stock, valued at approximately $1,245,000. Emerald Mutual Fund Advisers Trust owned approximately 0.41% of Zevia PBC at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Geode Capital Management LLC raised its stake in shares of Zevia PBC by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 539,652 shares of the company's stock valued at $2,262,000 after acquiring an additional 3,177 shares in the last quarter. Marshall Wace LLP acquired a new stake in Zevia PBC in the 4th quarter valued at about $858,000. Renaissance Technologies LLC raised its position in Zevia PBC by 51.6% in the 4th quarter. Renaissance Technologies LLC now owns 150,726 shares of the company's stock valued at $632,000 after purchasing an additional 51,300 shares in the last quarter. Russell Investments Group Ltd. purchased a new position in shares of Zevia PBC in the 4th quarter valued at about $596,000. Finally, Northern Trust Corp grew its position in shares of Zevia PBC by 11.6% during the fourth quarter. Northern Trust Corp now owns 119,428 shares of the company's stock worth $500,000 after buying an additional 12,396 shares in the last quarter. 53.21% of the stock is currently owned by hedge funds and other institutional investors.
Zevia PBC Price Performance
Shares of NYSE:ZVIA traded down $0.18 during trading on Friday, hitting $2.17. 601,211 shares of the company were exchanged, compared to its average volume of 446,822. The firm's 50 day moving average price is $2.23 and its 200-day moving average price is $2.73. Zevia PBC has a 12-month low of $0.62 and a 12-month high of $4.99. The stock has a market capitalization of $159.51 million, a P/E ratio of -5.71 and a beta of 0.77.
Analysts Set New Price Targets
Several research firms have recently issued reports on ZVIA. Telsey Advisory Group decreased their price objective on shares of Zevia PBC from $4.00 to $3.00 and set a "market perform" rating for the company in a research report on Thursday, February 27th. The Goldman Sachs Group lifted their price target on Zevia PBC from $1.15 to $3.75 and gave the stock a "neutral" rating in a report on Tuesday, January 14th.
Read Our Latest Stock Report on ZVIA
About Zevia PBC
(
Free Report)
Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated beverages in the United States and Canada. It offers soda, energy drinks, organic tea, and kidz drinks. The company offers its products through a network of food, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as grocery distributors and natural product stores and specialty outlets.
Recommended Stories

Before you consider Zevia PBC, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zevia PBC wasn't on the list.
While Zevia PBC currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.